NO992010D0 - New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes - Google Patents
New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromesInfo
- Publication number
- NO992010D0 NO992010D0 NO992010A NO992010A NO992010D0 NO 992010 D0 NO992010 D0 NO 992010D0 NO 992010 A NO992010 A NO 992010A NO 992010 A NO992010 A NO 992010A NO 992010 D0 NO992010 D0 NO 992010D0
- Authority
- NO
- Norway
- Prior art keywords
- syndromes
- estrogen
- prevention
- treatment
- related diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK120096 | 1996-10-28 | ||
PCT/DK1997/000480 WO1998018773A1 (en) | 1996-10-28 | 1997-10-28 | Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
Publications (2)
Publication Number | Publication Date |
---|---|
NO992010D0 true NO992010D0 (en) | 1999-04-27 |
NO992010L NO992010L (en) | 1999-06-25 |
Family
ID=8102107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO992010A NO992010L (en) | 1996-10-28 | 1999-04-27 | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0937058A1 (en) |
JP (1) | JP2001502705A (en) |
AU (1) | AU4700097A (en) |
CA (1) | CA2270113A1 (en) |
IL (1) | IL129622A0 (en) |
NO (1) | NO992010L (en) |
WO (1) | WO1998018773A1 (en) |
ZA (1) | ZA979642B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000039120A2 (en) * | 1998-12-30 | 2000-07-06 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
EP1809618B1 (en) * | 2004-09-21 | 2013-07-17 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
ES2516067T3 (en) * | 2004-09-21 | 2014-10-30 | Mei Pharma, Inc. | Substituted Chroman Derivatives, Medicines and Therapy |
US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
ATE532777T1 (en) | 2004-09-21 | 2011-11-15 | Marshall Edwards Inc | SUBSTITUTED CHROMEDER DERIVATIVES, MEDICATIONS AND APPLICATIONS IN THERAPY |
CA2816322A1 (en) | 2010-11-01 | 2012-05-10 | Marshall Edwards, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
EP2953938B1 (en) * | 2014-02-07 | 2017-08-02 | Novogen Ltd. | Functionalised benzopyran compounds and use thereof |
AU2016215515B2 (en) | 2015-02-02 | 2020-04-30 | Mei Pharma, Inc. | Combination therapies |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3340276A (en) * | 1964-04-01 | 1967-09-05 | Ciba Geigy Corp | 3, 4-diphenyl-chromans |
DE1543749A1 (en) * | 1966-02-16 | 1969-12-11 | Merck Ag E | Process for the preparation of 3,4-cis-4-aryl-isoflavans |
US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
HUP9702244A3 (en) * | 1995-01-13 | 1999-12-28 | Novo Nordisk As | Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders |
-
1997
- 1997-10-28 CA CA002270113A patent/CA2270113A1/en not_active Abandoned
- 1997-10-28 IL IL12962297A patent/IL129622A0/en unknown
- 1997-10-28 AU AU47000/97A patent/AU4700097A/en not_active Abandoned
- 1997-10-28 JP JP10519939A patent/JP2001502705A/en active Pending
- 1997-10-28 EP EP97909217A patent/EP0937058A1/en not_active Withdrawn
- 1997-10-28 WO PCT/DK1997/000480 patent/WO1998018773A1/en not_active Application Discontinuation
- 1997-10-28 ZA ZA9709642A patent/ZA979642B/en unknown
-
1999
- 1999-04-27 NO NO992010A patent/NO992010L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU4700097A (en) | 1998-05-22 |
JP2001502705A (en) | 2001-02-27 |
EP0937058A1 (en) | 1999-08-25 |
WO1998018773A1 (en) | 1998-05-07 |
ZA979642B (en) | 1998-04-28 |
CA2270113A1 (en) | 1998-05-07 |
NO992010L (en) | 1999-06-25 |
IL129622A0 (en) | 2000-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO944857D0 (en) | Fluorenyl-containing metallocenes, process for their preparation and process for polymerization of olefins using the metallocenes | |
NO954942L (en) | New erythromycin derivatives, processes for their preparation and use of the derivatives as drugs | |
NO992641D0 (en) | Mixtures and Methods for the Treatment or Prevention of Inflammatory Diseases | |
ATE350364T1 (en) | ADAMANTAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND CARDIOVASCULAR DISEASES | |
NL1001338C2 (en) | 2-Hydroxyphenyltriazines, process for their preparation and use of UV absorbers. | |
NO900613D0 (en) | PROCEDURE FOR THE PREPARATION OF ACTIVATED CHITOSANES AND USE IN THE PREPARATION OF CHITOSANDER DERIVATIVES. | |
TR199500952A2 (en) | New n-benzylindole and benzopyrazole derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effect. | |
NO20005143L (en) | Methods and compositions for delaying the crosslinking of crosslinkable polysaccharide based materials lost through circulation | |
NO864241L (en) | PROCEDURE FOR BLACKING CELLULOSMASS OR FRAGMENT THEREOF, PLANT FOR USE BY IMPLEMENTATION OF THE PROCEDURE AND SCREW PRESSURE, SPECIFICALLY FOR USE BY THE PROCEDURE UNDER THE APPLICATION. | |
NO911956L (en) | PROCEDURE FOR THE PREPARATION OF OXYDANT SENSITIVE AND INSENSITIVE, AROMATIC ESTERS AS HUMAN NEUTROPHIL ELASTASE INHIBITORS | |
NO992010D0 (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO995723L (en) | New triptolide derivatives useful in the treatment of autoimmune diseases | |
NO992009D0 (en) | New trans-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO903594D0 (en) | PROCEDURE FOR THE PULVERIZATION OF MATERIALS AND INSTALLATIONS FOR IMPLEMENTING IT. | |
NO171484C (en) | APPLICATION OF SUGARCARCOOL, POLYOXYLYCYLENETS OR ETHMONOSACCHARIDE OR MIXTURES THEREOF BASED FOR SOMATOSTATINES AND CALCITONINES FOR AA INCREASED BIOTAILABILITY OF THE PEPTIDES ORAL OR RECTAL. | |
NO992008D0 (en) | New (+) enantiomers of cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO992005D0 (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO992003L (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO992002D0 (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO995722D0 (en) | New triptolide derivatives useful in the treatment of autoimmune diseases | |
IT1278056B1 (en) | DERIVATIVES OF S-TRIAZINE, THEIR PREPARATION AND THEIR USE AS UV ABSORBENTS. | |
NO992004D0 (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO992006D0 (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO985535L (en) | Process for the preparation of 1,3-alkanediols | |
MX22991A (en) | SWEETENING AGENT DERIVED FROM L-ASPARTIC OR L-GLUTAMIC ACID AND THE PROCEDURE FOR ITS PREPARATION. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |